Join Dr. Conrad Hummel, Vice President of Business Development at SK pharmteco, as he discusses factors for selecting a CDMO partner for small molecule development. This session highlights SK pharmteco’s global capabilities, including advanced chromatography solutions, high potency manufacturing, and flexible production capacity. Dr. Hummel also discusses the company’s innovative approach to simplifying collaboration through digital platforms, transparent communication, and adaptable project management.